Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts

References

• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders4th ed. Washington, DC, American Psychiatric Association
   Google Scholar
• Anghelescu I, Klawe C, Singer P, Fehr C, Hiemke C, Quante A, et al. Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene. World J Biol Psychiatry 2009; 30: 1–8
   Google Scholar
• Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65(3)1157–1165
   PubMed Web of Science ®Google Scholar
• Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 2002; 110(1)1–7
   PubMed Web of Science ®Google Scholar
• Benjamin J, Greenberg B, Murphy DL, Li L, Patterson C, Hamer D. Mapping personality traits to genes: population and family association between the D4 dopamine receptor and measures of novelty seeking. Nat Genet 1996; 12(1)81–84
   PubMed Web of Science ®Google Scholar
• Brunner H, Nelen M, Breakefield X, Ropers H, van Oost B. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262: 578–580
   PubMed Web of Science ®Google Scholar
• Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, et al. Aggressive behavior and altered amount of brain serotonin and norepinerphrine in mice lacking MAOA. Science 1995; 268(5218)1763–1766
   PubMed Web of Science ®Google Scholar
• Chen YC, Ku CS. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID) in Chinese version. Kaohsiung Medical College, Taiwan 1993
   Google Scholar
• Chen ZY, Hotamisligil GS, Huang JK, Wen L, Ezzeddine D, Aydin-Muderrisoglu N, et al. Structure of the human gene for monoamine oxidase type. Nucleic Acids Res 1991; 16: 4537–4541
   Google Scholar
• Cloninger CR, Adolfsson R, Svrakic NM. Mapping genes for human personality. Nat Genet 1996; 12(1)3–4
   PubMed Web of Science ®Google Scholar
• Daglish MR, Williams TM, Wilson SJ, Taylor LG, Eap CB, Augsburger M., et al. Brain dopamine response in human opioid addiction. Br J Psychiatry 2008; 193(1)65–72
   PubMedGoogle Scholar
• Deckert J, Catalano M, Syagailo YV, Bosi M., Okladnova O, Di Bella D, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999; 8(4)621–624
   PubMed Web of Science ®Google Scholar
• Duaux E, Krebs MO, Loo H, Poirier MF. Genetic vulnerability to drug abuse. Eur Psychiatry 2000; 15(2)109–114
   PubMedGoogle Scholar
• Ebstein RP, Belmaker RH. Saga of an adventure gene: novelty seeking, substance abuse and the dopamine D4 receptor (DRD4) exon III repeat polymorphism. Mol Psychiatry 1997; 2(5)381–384
   PubMed Web of Science ®Google Scholar
• Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, et al. D4DR exon III polymorphism associated with the personality trait of Novelty Seeking in normal human olunteers. Nat Genet 1996; 12(1)78–80
   PubMed Web of Science ®Google Scholar
• Franke P, Nothen MM, Wang T, Knapp M, Lichtermann D, Neidt H, et al. DRD4 exon III VNTR polymorphism-susceptibility factor for heroin dependence? Results of a case-control and a family-based association approach. Mol Psychiatry 2000; 5(1)101–104
   PubMed Web of Science ®Google Scholar
• Gelernter J, Kranzler H, Coccaro E, Siever L, New A, Mulgrew CL. D4 dopamine receptor. DRD4 alleles and novelty seeking in substance-dependence, personality-disorder, and control subjects. Am J Hum Genet 1997; 61(5)1144–1152
   PubMedGoogle Scholar
• Gerra G, Garofano L, Bosari S, Pellegrini C, Zaimovic A, Moi G, et al. Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioral and personality correlates. J Neural Transm 2004; 111(5)611–621
   PubMedGoogle Scholar
• Grady DL, Chi HC, Ding YC, Smith M, Wang E, Schuck S, et al. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-de?cit hyperactivity disorder. Mol Psychiatry 2003; 8(5)536–545
   PubMedGoogle Scholar
• Grove WM, Eckert ED, Heston L, Bouchard TJ, Jr, Segal N, Lykken DT. Heritability of substance abuse and antisocial behavior: a study of monozygotic twins reared apart. Biol Psychiatry 1990; 27(12)1293–1304
   PubMedGoogle Scholar
• Hutchison KE, LaChance H, Niaura R, Bryan A, Smolen A. The DRD4 VNTR polymorphism influences reactivity to smoking cues. J Abnorm Psychol 2002a; 111(1)134–143
   PubMed Web of Science ®Google Scholar
• Hutchison KE, McGeary J, Smolen A, Bryan A, Swift RM. The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol 2002b; 21(2)139–146
   PubMedGoogle Scholar
• Imlah N. Addiction: substance abuse and dependency. Sigma, Cheshire 1989; 120–124
   Google Scholar
• Karlsson JL. Family transmission of schizophrenia: a review and synthesis. Br J Psychiatry 1982; 140: 600–606
   PubMed Web of Science ®Google Scholar
• Karlsson JL. Partly dominant transmission of schizophrenia in Iceland. Br J Psychiatry 1988; 152: 324–329
   PubMed Web of Science ®Google Scholar
• Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003; 160(4)687–695
   PubMed Web of Science ®Google Scholar
• Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 1997; 2(3)251–254
   PubMed Web of Science ®Google Scholar
• Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9(3)482–497
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005; 8(11)1450–1457
   PubMed Web of Science ®Google Scholar
• Li T, Xu K, Deng H, Cai G, Liu J, Liu X. Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol Psychiatry 1997; 2(5)413–416
   PubMedGoogle Scholar
• Li T, Zhu ZH, Liu X, Hu X, Zhao J, Sham PC, et al. Association analysis of polymorphism in the DRD4 gene and heroin abuse in Chinese subject. Am J Med Genet 2000; 96(5)616–621
   PubMedGoogle Scholar
• Lung FW, Tzeng DS, Shu BC. Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia. Schizophr Res 2002; 57(2–3)239–245
   PubMedGoogle Scholar
• Meyer RE. The disease called addiction: emerging evidence in a 200-year debate. Lancet 1996; 347(8995)162–166
   PubMed Web of Science ®Google Scholar
• Nanko S, Hattori M, Ikeda K, Saski T, Kazamatsuri H. Dopamine D4 receptor polymorphism and schizophrenia. Lancet 1993; 341(8846)689–690
   PubMed Web of Science ®Google Scholar
• Oak JN, Oldenhof J, Van Tol HH. The dopamine D (4) receptor: one decade of research. Eur J Pharmacol 2000; 405(1–3)303–327
   PubMed Web of Science ®Google Scholar
• Ono Y, Manki H, Yoshimura K, Muramatsu T, Mizushima H, Higuchi S, et al. Association between dopamine D4 receptor exon III polymorphism and novelty seeking in Japanese subjects. Am J Med Genet 1997; 74: 501–503
   PubMedGoogle Scholar
• Patel PI. Quest for the elusive genetic basis of Tourette syndrome. Am J Hum Genet 1996; 59(5)980–982
   PubMedGoogle Scholar
• Robbins TW, Everitt BJ. Drug addiction: bad habits add up. Nature 1999; 398(6728)567–570
   PubMedGoogle Scholar
• Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103(3)273–279
   PubMed Web of Science ®Google Scholar
• Saiz PA, Garcia-Portilla MP, Florez G, Arango C, Corcoran P, Morales B, et al. Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(4)695–700
   PubMedGoogle Scholar
• Schosser A, Fuchs K, Scharl T, Schloegelhofer M, Kindler J, Mossaheb N, et al. Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians. World J Biol Psychiatry 2008; 13: 1–8
   Google Scholar
• Shao C, Li Y, Jiang K, Zhang D, Xu Y, Lin L, et al. Dopamine D4 receptor polymorphism modulates cue-elicited heroin craving in Chinese. Psychopharmacology 2006; 186(2)185–190
   PubMedGoogle Scholar
• Syagailo YV, Stöber G, Grässle M, Reimer E, Knapp M, Jungkunz G, et al. Association analysis of the functional monoamine oxidase a gene promoter polymorphism in psychiatric disorders. Am J Med Genet 2001; 105(2)168–171
   PubMedGoogle Scholar
• Skowronek MH, Laucht M, Hohm E, Becker K, Schmidt MH. Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds. Neurogenetics 2006; 7(4)239–246
   PubMed Web of Science ®Google Scholar
• Szilagyi A, Boor K, Szekely A, Gaszner P, Kalasz H, Sasvari-Szekely M. Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence. Neuropsychopharmacol Hung 2005; 7(1)28–33
   PubMedGoogle Scholar
• Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Tanda G Science 1997; 276(5321)2048–2050
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, et al. Genetic in?uences on DSM-III-R drug abuse and dependence: a study of 3372 twin pairs. Am J Med Genet 1996; 67(5)473–477
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55(11)967–972
   PubMed Web of Science ®Google Scholar
• Vanyukov MM, Maher BS, Devlin B, Kirillova GP, Kirisci L, Yu LM, et al. The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. Psychiatr Genet 2007; 17(6)323–332
   PubMedGoogle Scholar
• Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, et al. Multiple dopamine D4 receptor variants in the human population. Nature 1992; 358(6382)149–152
   PubMed Web of Science ®Google Scholar
• Vanyukov MM, Maher BS, Devlin B, Kirillova GP, Kirisci L, Yu LM, et al. The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. Psychiatr Genet 2007; 17(6)323–332
   PubMedGoogle Scholar
• Vanyukov MM, Moss HB, Yu LM, Tarter RE, Deka R. Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. Am J Med Genet 1995; 60(2)122–126
   PubMed Web of Science ®Google Scholar
• Wedekind D, Jacobs S, Karg I, Luedecke C, Schneider U, Cimander K, et al. Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone. World J Biol Psychiatry 2008; 29: 1–10
   Google Scholar